PYPL
52
-2
CFG
74
2
FRT
41
-2
KMX
61
-3
NOV
52
-5
OI
42
-3
MCO
71
-7
MCD
52
-5
ADM
28
3
EBAY
42
-2
SNA
70
-5
KO
38
-3
GT
56
-3
F
56
-3
V
64
-2
DGX
48
11
MDLZ
32
-4
ABT
59
2
PSA
56
3
SHW
62
-6
PYPL
52
-2
CFG
74
2
FRT
41
-2
KMX
61
-3
NOV
52
-5
OI
42
-3
MCO
71
-7
MCD
52
-5
ADM
28
3
EBAY
42
-2
SNA
70
-5
KO
38
-3
GT
56
-3
F
56
-3
V
64
-2
DGX
48
11
MDLZ
32
-4
ABT
59
2
PSA
56
3
SHW
62
-6
Financhill
Back

Pacific Biosciences of California Vs. Repligen Industry Stock Comparison

Sell
38

PACB
Pacific Biosciences of California

Last Price:
1.60
Seasonality Move:
21.6%
Sell
30

RGEN
Repligen

Last Price:
124.90
Seasonality Move:
7.3%
Sell
38
Pacific Biosciences of California (PACB) is a Sell

Is Pacific Biosciences of California a Buy, Sell or Hold?

  • The current Pacific Biosciences of California [PACB] share price is $1.60. The Score for PACB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • PACB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Repligen (RGEN) is a Sell

Is Repligen a Buy, Sell or Hold?

  • The current Repligen [RGEN] share price is $124.73. The Score for RGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PACB Stock Price Chart

What is Pacific Biosciences of California's stock price today?

  • The Pacific Biosciences of California share price today is $1.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing selling pressure, which indicates risk of future bearish movement.

RGEN Stock Price Chart

What is Repligen's stock price today?

  • The Repligen share price today is $124.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGEN is experiencing selling pressure, which indicates risk of future bearish movement.

PACB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 37.01 Sell
Chaikin Money Flow: -17716950 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.8 - 2.38) Sell
Bollinger Bands (100): (1.43 - 2.07) Sell

RGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 36.22 Sell
Chaikin Money Flow: -1285419 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (134.94 - 146.38) Sell
Bollinger Bands (100): (130 - 153.64) Sell

PACB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.19 Sell
20-day SMA: 2.11 Sell
50-day SMA: 1.91 Sell
200-day SMA: 2.5 Sell
8-day EMA: 2.04 Sell
20-day EMA: 2.08 Sell
50-day EMA: 1.95 Sell
200-day EMA: 3.05 Sell

RGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 142.02 Sell
20-day SMA: 140.23 Sell
50-day SMA: 141.19 Sell
200-day SMA: 157.58 Sell
8-day EMA: 139.7 Sell
20-day EMA: 140.54 Sell
50-day EMA: 141.71 Sell
200-day EMA: 151.3 Sell

Pacific Biosciences of California Earnings Growth & PACB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $0.17 per share.

Repligen Earnings Growth & RGEN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.22 per share.

Pacific Biosciences of California Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Repligen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):